Chiome Bioscience Inc.
株式会社カイオム・バイオサイエンス
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4583
FY2025 · 2025-12-31
| Gross margin | 59.9% |
| Operating margin | -165.1% |
| Net margin | -165.6% |
| Return on equity | — |
| Return on assets | -56.9% |
| Revenue growth (YoY) | -24.0% |
| EPS (basic) | ¥-14.47 |
| EPS growth (YoY) | — |
| Current ratio | 4.13x |
| Equity ratio | 64.1% |
| Book value / share | ¥16.18 |
| Free cash flow | -976 M |